C5aR antagonists
US10035768B2 · kind B2 · utility
22Cited by
17References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 2017 |
| Grant date | Jul 31, 2018 |
| Priority date | — |
| Expiry date | Oct 2, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.